Background/aim: To evaluate the efficacy and tolerability of postoperative depot medroxyprogesterone acetate (DMPA) versus postoperative continuous oral contraceptive (OC) pills in the treatment of endometriosis-associated pain.
Methods: After a conservative surgery, 84 patients with symptomatic endometriosis were randomized to receive either intramuscular DMPA (150 mg) every 12 weeks for 24 weeks or continuous OC pills (ethinyl estradiol 0.03 mg and gestodene 0.075 mg) daily for 24 weeks. At weeks 12 and 24 of the treatment phase, patients rated their satisfaction with treatment and reported pain improvement and adverse effects.
Results: There was no significant difference in the percentages of patients who reported satisfaction between the DMPA group and the OC group at weeks 12 and 24 (92.9 vs. 90.5%, and 92.9 vs. 88.1%, respectively). The rates of withdrawal because of persistent pain or side effects in the two groups were similar. Pain scores improved significantly in both groups, but dysmenorrhea scores on a visual analog scale at week 24 were significantly higher in the OC group than in the DMPA group (p = 0.039).
Conclusion: Both postoperative DMPA and postoperative OC pills for 24 weeks were found to be effective and acceptable options for treating endometriosis-associated pain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000337713 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Self-Cascading Catalytic Therapy and Antigen Capture Scaffold-Mediated T Cells Augments for Postoperative Brain Immunotherapy.
Small
December 2024
Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, 300044, Taiwan.
The recruitment of T lymphocytes holds great potential for suppressing the most aggressive glioblastoma (GBM) recurrence with immunotherapy. However, the phenomenon of immune privilege and the generally low immunogenicity of vaccines often reduce the presence of lymphocytes within brain tumors, especially in brain tumor recurrence clusters. In this study, an implantable self-cascading catalytic therapy and antigen capture scaffold (CAS) that can boost catalytic therapy efficiency at post-surgery brain tumor and capture the antigens via urethane-polyethylene glycol-polypropylene glycol (PU-EO-PO) segments are developed for postoperative brain immunotherapy.
View Article and Find Full Text PDFEfficacy of Transdermal Buprenorphine Patch in Postoperative Pain Management in Oral and Maxillofacial Surgery.
J Maxillofac Oral Surg
October 2024
Department of Oral Maxillofacial Surgery, Vydehi Institute of Dental Sciences, #82 EPIP Zone, Near BTMC 18th Depot, Vijayanagar, Whitefield, Bangalore, 560066 India.
Article Synopsis
- The study aimed to assess the effectiveness of transdermal Buprenorphine patches in managing postoperative pain following major oral and maxillofacial surgeries done under general anesthesia, involving 100 participants aged 18-60.! -
- Results showed that the average pain score (measured via a visual analogue scale) was lower in males (3.9) compared to females (4.4), with a significant proportion of trauma patients requiring fewer additional analgesics than those with other pathologies.! -
- The study concluded that Buprenorphine patches provide a high level of pain relief, are cost-effective, improve patient compliance, and have fewer side effects, making them a promising option for postoperative pain management.!
Injectable polypeptide-polysaccharide depot for preventing postoperative tumor recurrence by concurrent chemotherapy and brachytherapy.
Mater Today Bio
October 2024
State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institutes of Health Science, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, PR China.
Chemotherapy and radiotherapy in combination with sequence regimens are recognized as the current major strategy for suppressing postoperative tumor recurrence. However, systemic side effects and poor in-field cooperation of the two therapies seriously impair the therapeutic efficacy of patients. The combination of brachytherapy and chemotherapy through innovative biomaterials has proven to be an important strategy to achieve synergistic effects of radiotherapy and chemotherapy in-time and in-field.
View Article and Find Full Text PDFComparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery.
Acta Ophthalmol
August 2024
Department of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
Article Synopsis
- Treatment with glucocorticoids after cataract surgery in children is important to avoid inflammation but can increase the risk of secondary glaucoma.
- This study compared outcomes of high-dose versus low-dose glucocorticoid treatment in Danish children after cataract surgery, analyzing data from over 267 cases.
- Results indicated that low-dose treatment was linked to a lower risk of glaucoma for children with larger axial lengths (≥18 mm), while high-dose glucocorticoids may need to be restricted in these patients.
Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia.
Br J Clin Pharmacol
November 2024
Inria & CMAP, Ecole Polytechnique, CNRS, Institut Polytechnique de Paris, Paris, France.
Aims: Intraoperative hypotension is a risk factor for kidney, heart and cognitive postoperative complications. Literature suggests that the use of low-dose peripheral norepinephrine (NOR) reduces organ dysfunction, yet its administration remains unstandardized. In this work we develop a pharmacokinetic (PK)/pharmacodynamic (PD) model of NOR and its effect on mean arterial pressure (MAP).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!